First thing: What have I done to not get an invite :-(?
Maybe I am too frank!
What do these papers say:
There are three broad areas: systemic inflammation, compartmentalized inflammation and non-inflammatory neurodegeneration. They say "anti-inflammatory treatments are unlikely to be beneficial in this (progressive) stage of the disease, but neuroprotective and repair-inducing strategies may still be effective."
They will say "this is why we won't support #ChariotMS, because it won't work". I say "Is there ambition to try and make a difference?" We think we need to deal with inflammation that occurs throughout MS, and likewise we need to protect and repair throughout MS
Last Years Burning Debate @ ECTRIMS
Gave us a Flavour of What Some of our Colleagues
Think about Trials in Advance MS If you are sensitive to views, that you don't want to hear Don't listen or press the triangle!